Bioequivalence Study of Empagliflozin And Linagliptin Tablets in Healthy Chinese Subjects
Clinical trial NCT05956522 · COMPLETED
Trial details
- NCT number
- NCT05956522
- Sponsor
- The Affiliated Hospital of Qingdao University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2022-11-23
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.